IMVT-1401-3101: A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG)

Grants and Contracts Details

StatusActive
Effective start/end date10/12/228/16/24

Funding

  • Syneos Health LLC: $50,512.00